CORONA Remedies Limited (NSE:CORONA)
2,228.00
+27.20 (1.24%)
Last updated: Sep 11, 2026, 3:29 PM IST
CORONA Remedies Company Description
CORONA Remedies Limited, a pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
It provides products in women’s healthcare, cardio-diabeto, pain management, urology, thyroid management, respiratory, nutraceuticals, gastroenterology, and other therapeutic areas.
The company was incorporated in 2004 and is based in Ahmedabad, India.
CORONA Remedies Limited
| Country | India |
| Founded | 2004 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 5,153 |
| CEO | Niravkumar Mehta |
Contact Details
Address: Corona House Ahmedabad, 380059 India | |
| Phone | 91 79 4023 3000 |
| Website | coronaremedies.com |
Stock Details
| Ticker Symbol | CORONA |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Niravkumar Kirtikumar Mehta | Founder, MD, Chief Executive Officer and Director |
| Ankurbhai Kirtikumar Mehta | Co-Founder, Joint MD and Director |
| Viral Bhupendrabhai Sitwala | Whole-Time Director |
| Bhavin Naresh Bhagat | Chief Financial Officer |
| Chetna Prabhat Kumar Dharajiya | Company Secretary and Compliance Officer |
| Bhaven Shah | President of Commercial |
| Vijay Charlu | President of India Business |
| Sangeeta Thaker | President of Global Business |
| Tejas Kothari | Vice President of Corporate Strategy and Business Development |